“No Time to Wait” Advertising campaign – Pfizer’s ‘Blockbuster’ Drug to Treat Heart Conditions, Including Those Caused by Covid Vaccines

Eliquis, the top-selling blood thinner and atrial fibrillation (AF) drug for the very heart conditions associated with people who received Covid vaccines – developed and marketed by Pfizer and Bristol Myers Squibb, delivering more than $9 billion in annual revenue.

Two major pharmaceutical companies chose February, the month of love — or hearts — to launch an advertising campaign urging people experiencing heart issues for the first time to visit their doctors.

Pfizer and Bristol Myers Squibb (BMS) this month revived the “No Time to Wait” ad campaign, spending $1.28 million on TV ads alone.

The campaign warns anyone experiencing palpitations and shortness of breath that they may be at increased risk of developing atrial fibrillation (AF), deep vein thrombosis (DVT), other types of blood clots and strokes — the same types of cardiovascular ailments found among people who have received COVID-19 vaccines.

The campaign urges viewers to seek early medical attention in order to reduce the risk of these serious complications.

“Early medical attention” could include prescription drugs — including Eliquis, developed and marketed by none other than Pfizer and BMS.

According to industry publication Fierce Pharma:

“The aim is to get patients back into their doctors’ offices — and of course, if needed, be diagnosed with any relevant condition that may require them to take a blood thinner, such as Eliquis.”

Eliquis, described as a “blockbuster blood thinner and atrial fibrillation (AF) drug,” is a major revenue generator for the Pfizer-BMS alliance, delivering more than $9 billion in annual revenue — far more than competing drugs such as Xarelto (produced by Bayer in conjunction with Johnson & Johnson), and Pradaxa, produced by Boehringer Ingelheim.

Pfizer and BMS relaunched the “No Time to Wait” campaign in conjunction with several advocacy organizations and medical societies, including World Thrombosis Day, which expressed support for the Pfizer-BMS initiative as a means of “educating” the public.

Characterized as a “surround-sound campaign,” Pfizer-BMS use television, radio and social media to deliver the “No Time to Wait” message to the public.

As part of the campaign, a DVT and pulmonary embolism (PE) television advertisement debuted on Valentine’s Day, Feb. 14. The ad showed two patients describing how they “didn’t wait” to speak to their doctors about the AF, DVT and PE symptoms they had begun to experience while performing everyday activities.

Speaking to the camera, the two actors describe symptoms, such as shortness of breath and a racing heart, which are potential indicators of AF, DVT and PE.

Official campaign literature urges the public to take action:

“Right now, people may be weighing a decision to visit a healthcare provider. However, symptoms like swelling, pain, tenderness or redness in the leg, thigh or pelvis can possibly be related to a potentially serious condition such as deep vein thrombosis (DVT). It’s critical to not brush off these symptoms.”

BMS, via its spokesperson, described the reasons for relaunching the campaign:

“We received so much positive feedback from patients and advocates on the impact this campaign had on patients, we knew it was our responsibility to continue to evolve the program and further get the message out.

“In the middle of 2021, we decided to evolve the campaign, with new insight that symptomatic people at risk for AFib or DVT/PE can often dismiss their symptoms or misattribute [emphasis added] them to other health and lifestyle factors.”

Could “misattribute,” in this instance, actually refer to cases where those who had recently received a COVID vaccine experienced the onset of heart-related conditions, in some cases leading to their deaths?

Is Pfizer benefitting from vaccine-induced ailments?

Could the relaunching of the “No Time to Wait” campaign represent an effort by Pfizer to engage in damage control from the increase in vaccine-induced heart conditions — while benefiting from the sale of a drug used to address those same ailments?

There are several objectives Pfizer and BMS could accomplish with the campaign.

First, by launching an advertising campaign warning people they may be at risk of certain heart conditions, Pfizer and BMS are in a sense “naturalizing” heart ailments in young and/or healthy individuals.

Second, by “naturalizing” the prevalence and likelihood of such heart conditions, these companies may deflect blame for these conditions from COVID vaccines, including the Pfizer-BioNTech vaccine.

Third, by referring patients to their doctors, the Pfizer-BMS alliance may directly benefit financially from the increased prevalence of heart ailments and conditions in the vaccinated public — as doctors prescribe more Eliquis, the top-selling blood thinner and AF drug, to treat their symptoms.

‘Normalizing’ heart conditions in young and healthy

According to Pfizer and the Centers for Disease Control and Prevention (CDC), even “the healthiest athletes” are now at risk for blood clots, as stated in an urgent warning issued this month.

The media and health authorities in recent months have proffered multiple explanations for why healthy people are developing blood clotting and heart conditions, blaming everything from weather and energy bills to cannabis use — but not COVID vaccines.

Here are some examples:

• September 2021: The Times of India ran a story on a “doctors’ reminder” that “nobody is too young for a heart attack.”
• September 2021: A study indicated that cannabis use doubled the risk of heart attacks in young adults.
• October 2021: The New York Post reported on “[t]he little-known heart attack that’s striking ‘fit and healthy’ women as young as 22.”
• November 2021: British tabloid The Sun reported on “[t]he ways cold weather can affect your body — from winter vagina to blood clots.”
• November 2021: A Times of India report asked why heart attacks are “becoming common in ‘seemingly’ fit people.”
• November 2021: Healthline reported e-cigarettes can raise the risk of heart disease and stroke.
• December 2021: Another British tabloid, Express, warned about the “healthy” diet that “may ‘increase’ your risk of having a heart attack.”
• January 2022: Norton Health informed us that “[p]reventing heart disease in children is becoming more urgent as more kids develop heart disease.”
• January 2022: A report is published warning that “sports can break your heart in more ways than one.”
• January 2022: A report by CT (Connecticut) Insider indicated more people were suffering from heart disease and strokes “after COVID.”
• January 2022: The Daily Mail warned the “[r]isk of heart problems could be increased even if you drink less than NHS weekly units,” referring to recommendations made by the UK’s National Health Service.
• January 2022: The Sun ran a report claiming weather can “harm” one’s health, leading to heart attacks, stroke or gout.
• January 2022: Another report by The Sun warned 300,000 Brits were “living with [a] stealth disease that could kill within 5 years.” The “stealth disease” in question is aortic valve stenosis, a condition where the heart’s aortic valve narrows.
• February 2022: Nature magazine reported the risk of heart disease “soars after COVID — even with a mild case.”
• February 2022: A doctor interviewed on the UK’s ITV warned an increase in energy bill amounts may cause heart attacks and strokes.

Mark Crispin Miller, professor of media, culture and communication at New York University and founder of News from Underground compiled a list of reports like those listed above.

In looking at incidents and reports during the week of Feb. 8-14 alone, Crispin told readers:

“Before we note all those whose ‘sudden deaths’ made news just this past week — ‘unexpected deaths’ with no reported cause, or due to heart attacks, strokes, blood clots, cardiac arrest or swift, aggressive cancers (all known to be ‘adverse events’ post-‘vaccination’) — let’s review how this unprecedented global spike in sudden death has been deliberately obscured by ‘our free press.’”

Miller highlighted an ABC News report, “‘Broken heart’ cases surge during COVID, especially among women.”

In another example, Science magazine reported geneticists found the answer to “sudden unexplained child deaths.”

Downplaying of the connection between the COVID vaccines and serious heart conditions often has involved high-profile athletes.

For instance, 33-year-old soccer star Sergio Aguero of FC Barcelona was forced to announce his retirement in December 2021, after suffering chest pains and dizziness during a match in October 2021. He never played again.

According to Aguero’s cardiologist, the vaccine was not the reason for his ailment and retirement.

However, Aguero himself, in a Twitter question-and-answer session earlier this month, did not reject this possibility, stating: “I don’t know if Covid or [the] vaccine caused my retirement.”

Media, however, continue to promote the narrative that vaccines have nothing to do with the surge in sudden illnesses or deaths among athletes.

For example, Miller cited a Feb. 1 Washington Post article describing stories of athletes dying due to COVID vaccination as a “falsehood.”

Miller then compared what he described as the “disgraceful” Washington Post report with a documented timeline of athletes who suffered from heart failure between March 2021 and January 2022.

This string of incidents is further illustrated and detailed by the “Real Science” blog, which found 707 such incidents as of this writing and demonstrated in graphical form the sharp increase in heart failure incidents involving athletes over the course of 2021 and into 2022, as COVID vaccination uptake increased.

Nevertheless, Politifact, in December 2021, assured the public “[t]here’s no proof athletes collapsed with heart issues because of COVID-19 vaccination,” while in November 2021, U.S. News & World Report warned “COVID may trigger [a] heart condition in young athletes.”

The views and opinions expressed in this article are those of the authors and do not necessarily reflect the views of Children’s Health Defense.